Article
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.
Journal of clinical psychopharmacology - 1 Apr 2004
Eap Chin B, Bender Stefan, Jaquenoud Sirot E, Cucchia Gianni, Jonzier-Perey Michèle, Baumann Pierre, Allorge Delphine, Broly Franck
Abstract excerpt
Clozapine (CLO), an atypical antipsychotic, depends mainly on cytochrome P450 1A2 (CYP1A2) for its metabolic clearance. Four patients treated with CLO, who were smokers, were nonresponders and had low plasma levels while receiving usual doses. Their plasma levels to dose ratios of CLO (median; range, 0.34; 0.22 to 0.40 ng x day/mL x mg) were significantly lower than ratios calculated from another study with 29...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
